IL28B polymorphism,Explanation for Different Responses to Therapy in Hepatitis C Patients
S. IL28B polymorphism,Explanation for Different Responses to Therapy in Hepatitis C Patients,
Online ahead of Print
Implication for health policy/practice/research/medical education: This article focuses on impact of IL28B polymorphisms on hepatitis C outcomes. This study is recommended to clinicians and researchers in the field of viral hepatitis.
Please cite this paper as: Sharafi H, Alavian SM. IL28B polymorphism, explanation for Different Responses to Therapy in Hepatitis C patients. Hepat Mon. 2011; 11(12):958-9. DoI: 10.5812/kowsar.1735143X.794
Polymorphism, Genetic; Hepatitis C; IL28B Protein, Human
© 0, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.